A drug that stops cancer treatments damaging ovaries could preserve patients’
fertility. Researchers at the Memorial Sloan-Kettering Cancer Center and
Massachusetts General Hospital injected a compound called
sphingosine-1-phosphate into the ovaries of mice. This prevented a lipid in the
membrane of an egg cell being converted into another lipid called ceramide and
starting a chain reaction that ends in cell suicide (Nature Medicine,
vol 6, p 1109). “If they have stopped [cell death] and produced normal embryos
from the ovaries, this is fantastic,” says Geraldine Hartshorne of the University of Warwick.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features

Environment
June heatwave may have killed around 20,000 people in Europe
News

Physics
Random wobbles in time could finally solve gravity’s greatest mystery
News

Life
Synthetic biology may finally be ready to solve life's biggest mystery
Leader

Environment
Geoengineering could expose plane passengers to sulphuric acid
News
Popular articles
Trending New Scientist articles
1
Humans sleep the least of all apes – is it the secret to our success?
2
A type of fibre that stimulates GLP-1 release approved for use in food
3
The weirdness of neutrinos could completely rewrite particle physics
4
Babies are born with the neural foundations for maths
5
This physicist is hunting for the biggest black hole in the universe
6
Random wobbles in time could finally solve gravity’s greatest mystery
7
Slowdown of AMOC ocean current may be gradual and reversible
8
The best new science-fiction novels published in July 2026
9
What is 'SpudCell'? Arguably the greatest bioengineering feat yet
10
The 4 must-watch science-fiction films of the year so far